Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
- PMID: 33208870
- PMCID: PMC7674435
- DOI: 10.1038/s41598-020-77068-0
Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
Abstract
MicroRNA-200 (miR-200) family is highly expressed in ovarian cancer. We evaluated the levels of family members relative to the internal control miR-103a in ovarian cancer and control blood specimens collected from American and Hong Kong Chinese institutions, as well as from a laying hen spontaneous ovarian cancer model. The levels of miR-200a, miR-200b and miR-200c were significantly elevated in all human cancer versus all control blood samples. Further analyses showed significantly higher miR-200 levels in Chinese control (except miR-429) and cancer (except miR-200a and miR141) samples than their respective American counterparts. Subtype-specific analysis showed that miR-200b had an overall elevated level in serous cancer compared with controls, whereas miR-429 was significantly elevated in clear cell and endometrioid cancer versus controls. MiR-429 was also significantly elevated in cancer versus control in laying hen plasma samples, consistent with the fact that endometrioid tumor is the prevalent type in this species. A neural network model consisting of miR-200a/200b/429/141 showed an area under the curve (AUC) value of 0.904 for American ovarian cancer prediction, whereas a model consisting of miR-200b/200c/429/141 showed an AUC value of 0.901 for Chinese women. Hence, miR-200 is informative as blood biomarkers for both human and laying hen ovarian cancer.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.Clin Transl Oncol. 2015 Oct;17(10):779-87. doi: 10.1007/s12094-015-1303-1. Epub 2015 Jun 11. Clin Transl Oncol. 2015. PMID: 26063644
-
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.BMC Cancer. 2012 Dec 28;12:627. doi: 10.1186/1471-2407-12-627. BMC Cancer. 2012. PMID: 23272653 Free PMC article.
-
Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3001-3005. doi: 10.31557/APJCP.2019.20.10.3001. Asian Pac J Cancer Prev. 2019. PMID: 31653147 Free PMC article.
-
Ovarian cancer update: lessons from morphology, molecules, and mice.Arch Pathol Lab Med. 2009 Nov;133(11):1775-81. doi: 10.5858/133.11.1775. Arch Pathol Lab Med. 2009. PMID: 19886711 Free PMC article. Review.
-
[Early malignant changes in ovarian epithelium--the relationship between histology and molecular biological change].Hum Cell. 2000 Mar;13(1):3-6. Hum Cell. 2000. PMID: 10937341 Review. Japanese. No abstract available.
Cited by
-
The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.Int J Mol Sci. 2022 Jun 27;23(13):7126. doi: 10.3390/ijms23137126. Int J Mol Sci. 2022. PMID: 35806128 Free PMC article. Review.
-
Diagnosis accuracy of the miR-200 family tumor marker series in ovarian cancer: a systematic review and meta-analysis.Transl Cancer Res. 2022 Jul;11(7):2283-2290. doi: 10.21037/tcr-22-864. Transl Cancer Res. 2022. PMID: 35966325 Free PMC article.
-
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.Cancers (Basel). 2021 Nov 23;13(23):5874. doi: 10.3390/cancers13235874. Cancers (Basel). 2021. PMID: 34884985 Free PMC article. Review.
-
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review.Front Oncol. 2024 Jul 26;14:1405267. doi: 10.3389/fonc.2024.1405267. eCollection 2024. Front Oncol. 2024. PMID: 39132504 Free PMC article.
-
Clinical significance of microRNA-200 and let-7 families expression assessment in patients with ovarian cancer.Ecancermedicalscience. 2021 Jun 14;15:1249. doi: 10.3332/ecancer.2021.1249. eCollection 2021. Ecancermedicalscience. 2021. PMID: 34267805 Free PMC article. Review.
References
-
- Reid, F. The World Ovarian Cancer Coalition Atlas- Global Trends in Incidence, Mortality and Survival. (World Ovarian Cancer Coalition, 2018).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical